Where promising science becomes enduring companies.
Where promising science becomes enduring companies.
Where promising science becomes enduring companies.
Where promising science becomes enduring companies.
Where promising science becomes enduring companies.
Portal combines capital, space, and hands-on operating expertise to turn high-conviction research into breakthrough businesses.
Portal combines capital, space, and hands-on operating expertise to turn high-conviction research into breakthrough businesses.
Portal combines capital, space, and hands-on operating expertise to turn high-conviction research into breakthrough businesses.
Our
Mission
Our
Mission
Our
Mission
We give top innovators in emerging ecosystems a clear path to build and fund their companies.
We give top innovators in emerging ecosystems a clear path to build and fund their companies.
We give top innovators in emerging ecosystems a clear path to build and fund their companies.
The problem
Breakthrough scientists often lack the capital, lab space, and operational support to build companies where they are, while investors can miss opportunities without close ties to universities.
Our approach
Crafted capital.
We surround science-driven entrepreneurs with the resources and community they need: seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.
OUR FOOTPRINT
A national presence.
A national presence.
A national presence.
A national presence.
Portal members access premium lab space, critical equipment, and a connected venture community, right where they’re building.
Portal members access premium lab space, critical equipment, and a connected venture community, right where they’re building.
FEATURED
Biotech’s Next Frontier: Emerging Hubs Built for Efficiency and Outsized Returns
Biotech’s Next Frontier: Emerging Hubs Built for Efficiency and Outsized Returns
Portal’s venture team recently studied 11,000 companies and nearly 30,000 financing deals and found that biotech startups in emerging U.S. markets have better investment returns, are more founder friendly, and reach clinical milestones faster than traditional biohubs.
Portal’s venture team recently studied 11,000 companies and nearly 30,000 financing deals and found that biotech startups in emerging U.S. markets have better investment returns, are more founder friendly, and reach clinical milestones faster than traditional biohubs.
Download the full white paper
You can build here.
You can build here.
You can build here.
Membership
Membership
Membership
Explore national benefits and local lab offerings.
Explore national benefits and local lab offerings.
→
Labs
Labs
Labs
Premium lab space, equipment, and community where you’re building.
Premium lab space, equipment, and community where you’re building.
→
About Portal
About Portal
About Portal
Our people, partners, and approach.
Our people, partners, and approach.
→
News
News
News
News from across the Portal community.
News from across the Portal community.
→
Connect
Connect
Connect
Tell us where you want to go next.
Tell us where you want to go next.
→
© 2026 Portal Innovations LLC
Capital. Space. Expertise.
